Neuroendocrine Tumor G2
3 clinical trials · Condition
◉ Watch Neuroendocrine Tumor G2
| Record | Firm | Date |
|---|---|---|
| Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors (NCT01841736) | National Cancer Institute (NCI) | 2013-09-20 |
Track Neuroendocrine Tumor G2 automatically
Every clearance here is in the API, with alerts when new ones post.